News
James Wynn critica o modelo de indicação da Hyperliquid em meio a dificuldades com uma perda de US$100 milhões.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback